ALX Oncology Holdings Inc. (ALXO) Misses Q2 EPS by 6c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q2 EPS of ($0.49), $0.06 worse than the analyst estimate of ($0.43).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• ADP Employment Change (Aug) 38K vs 47K Expected
• GlobalFoundries and RAAAM to develop next-gen on-chip memory for AI
• Deutsche Bank Upgrades Sirius XM Radio (SIRI) to Buy, 'mispriced based on a large disconnect between consensus estimates and what we believe the company can achieve